After PCI and 1 mo of DAPT for ACS, ticagrelor alone vs. continued DAPT for 11 mo reduced bleeding without increasing MACCE.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 39102721.
- Also identified by DOI 10.7326/ANNALS-24-00968-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ge Z, Kan J, Gao X, et al; ULTIMATE-DAPT investigators. <b>Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.</b> Lancet. 2024;403:1866-1878. 38599220.
Medical subject headings
- Acute Coronary Syndrome
- Aspirin
- Dual Anti-Platelet Therapy
- Percutaneous Coronary Intervention
- Platelet Aggregation Inhibitors
- Ticagrelor